Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement

Core Points - Shineco, Inc. has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed at a bid price of at least $1.00 per share for 15 consecutive business days from February 16, 2024, to March 8, 2024 [1] Company Overview - Shineco, Inc. focuses on providing safe, efficient, and high-quality health and medical products and services, aiming to improve the quality of life [2] - The company has developed 33 vitro diagnostic reagents and related medical devices and also produces and sells healthy and nutritious foods [2]